Skip to main content
Log in

Inclusion compounds of cystostatic active (C5H5)2VCl2 and (CH3C5H4)2VCl2 with α-, β- and γ-cyclodextrines: Synthesis, EPR study and microbiological behavior toward Escherichia coli

  • Published:
Central European Journal of Chemistry

Abstract

The inclusion of vanadocene dichloride (VDC) and 1,1′-dimethyl vanadocene dichloride (MeVDC) into cyclodextrines (α-CD, β-CD and γ-CD) was studied by EPR spectroscopy. It was found that VDC and MeVDC with β-CD and γ-CD form true inclusion compounds, but with α-CD, VDC and MeVDC gave only fine dispersion mixtures. The inclusion was validated by anisotropic EPR spectra of solid samples. In addition, the antimicrobial was validated by anisotropic EPR spectra of solid samples. In addition, the antimicrobial behavior (against E. coli) of each of the complexes was determined. It was established that not only did VDC and MeVDC cause elongation of E. coli, but also the new vanadocene inclusion complexes were effective in this regard.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V.J. Moebus, R. Stein, D.G. Kieback, I.B. Runnebaum, G. Sass and R. Kreienberg: “Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives”, Anticancer Research, Vol. 17, (1997), pp. 815–821.

    CAS  Google Scholar 

  2. G. Lümmen, H. Sperling, H. Luboldt, T. Otto and H. Rübben: “Phase II trial of titanocene dichloride in advanced renal-cell carcinoma”, Cancer Chemother. Pharmacol., Vol. 42, (1998), pp. 415–417.

    Article  Google Scholar 

  3. P. Köpf-Maier: “Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma”, Anticancer Research, Vol. 19, (1999), pp. 493–504.

    Google Scholar 

  4. N. Kroger, U.R. Kleeberg, K. Mross, L. Edler, G. Sass and D.K. Hossfeld: “Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer”, Onkologic, Vol. 23, (2000), pp. 60–62.

    Article  Google Scholar 

  5. P. Köpf-Maier and H. Köpf: “Non-Platinum-Group Metal Antitumor Agents: History, Current Status, and Perspectives”, Chem. Rev., Vol. 87, (1987), pp. 1137–1152.

    Article  Google Scholar 

  6. A. Harada and S. Takahashi: “Preparation and Properties of Cyclodextrin-Ferrocene Inclusion Complexes”, J. Chem. Soc.-Chem. Commun. (1984), pp. 645–646.

  7. A. Harada, Y. Hu, S. Yamamoto and S. Takahashi: “Preparation and Properties of Inclusion-Compounds of Ferrocene and Its Derivatives with Cyclodextrins”, J. Chem. Soc.-Dalton Trans., (1988), pp. 729–732.

  8. Y. Odagaki, K. Hirotsu, T. Higuchi, A. Harada and S. Takahashi: “X-Ray Structure of the α-Cyclodextrin Ferrocene (2-1) Inclusion Compound”, J. Chem. Soc.-Perkin Trans. 1, (1990), pp. 1230–1231.

    Article  Google Scholar 

  9. P. Ferreira, I.S. Goncalves, M. Pillinger, J. Rocha, P. Santos and J.J.C. Teixeira-Dias: “Modification of β-cyclodextrin with ferrocenyl groups by ring opening of an encapsulated 1 ferrocenophane”, Organometallics, Vol. 19 (2000), pp. 1455–1457.

    Article  CAS  Google Scholar 

  10. S.S. Braga, I.S. Goncalves, A.D. Lopes, M. Pillinger, J. Rocha, C.C. Romao and J.J.C. Teixeira-Dias: “Encapsulation of half-sandwich complexes of molybdenum with beta-cyclodextrin”, J. Chem. Soc-Dalton Trans., (2000), pp. 2964–2968.

  11. S. Lima, I.S. Goncalves, P. Ribeiro-Claro, M. Pillinger, A.D. Lopes, P. Ferreira J.J.C. Teixeira-Dias, J. Rocha and C.C. Romao: “Interactions of cationic and neutral molybdenum complexes with β-cyclodextrin host molecules”, Organometallics, Vol. 20 (2001), pp. 2191–2197.

    Article  CAS  Google Scholar 

  12. I. Turel, A. Demsar and J. Kosmrlj: “The interactions of titanocene dihalides with alpha-, beta- and gamma-cyclodextrin host molecules”, J. Incl. Phenom. Macrocycl. Chem., Vol. 35, (1999), pp. 595–604.

    Article  CAS  Google Scholar 

  13. C.S. Lu, Y. Zou, J.L. Xie, Z.P. Ni, H.Z. Zhu, Q.J. Meng and Y.G. Yao: “An antitumor agent of β-cyclodextrin-modified titanocene complex: Synthesis and characterization”, Chem. Pharm. Bull., Vol. 51 (2003), pp. 864–866.

    Article  CAS  Google Scholar 

  14. S.S. Braga, I.S. Gonçalves, M. Pillinger, P. Ribeiro-Claro and J.J.C. Teixeira-Dias: “Experimental and theoretical study of the interaction of molybdenocene dichloride (Cp2MoCl2) with β-cyclodextrin”, J. Organomet. Chem., Vol. 632, (2001), pp. 11–16.

    Article  CAS  Google Scholar 

  15. E. Fenyvesi, L. Szente, N.R. Russell and M. McNamara: Comprehensive Supramolecular Chemistry, J.L. Atwood, J.E.D. Davies, D.D. MacNicol, F. Vögtle, J.M. Lehn, J. Szejtli and T. Osa (Eds.), Pergamon, Oxford, 1996, Vol. 3, chap. 10.

    Google Scholar 

  16. I. Pavlík and J. Vinklárek: “Hydrolysis Behavior of the Antitumor Agent Vanadocene Dichloride in Strongly Acid, Neutral and Alkaline Aqueous-Media-an EPR Study”, Eur. J. Solid State Inorg. Chem., Vol. 28, (1991), pp. 815–827.

    Google Scholar 

  17. J. Honzíček, P. Nachtigall, I. Císařova and J. Vinklárek: “Synthesis, characterization and structural investigation of the first vanadocene(IV) carboxylic acid complexes prepared from the vanadocene dichloride”, J. Organomet. Chem., Vol. 689, (2004), pp. 1180–1187.

    Article  Google Scholar 

  18. B. Rosenberg and L. van Camp: “The inhibition of grwoth and cell division in Escherichia coli)”, J. Biol. Chem., Vol. 242, (1967), pp. 1347–1352.

    CAS  Google Scholar 

  19. I.C. Tornieporth-Oetting and P.S. White: “Ionic Titanocene(IV) α-Amino-Acid Complexes of Dl- Phenylalanine and Dl-4-Fluorophenylalanine-Synthesis, Characterization, and Investigation of the Antimicrobial Behavior toward Escherichia-Coli”, Organometallics, Vol. 14, (1995), pp. 1632–1636.

    Article  CAS  Google Scholar 

  20. E. Diana, R. Rossetti, P.L. Stanghellini and S.F.A. Kettle: “Vibrational study of (η 5-cyclopentadienyl) metal complexes”, Inorg. Chem., Vol. 36, (1997), pp. 382–391.

    Article  CAS  Google Scholar 

  21. J. Petersen and F. Dahl: “Synthesis and Structural Characterization by X-Ray Diffraction and Electron Paramagetic Resonance Single-Crystal Techniques of V(η 5-C5H4CH3)2Cl2 and Ti(η 5-C5H4CH3)2Cl2. A Study of the Distribution of the Unpaired Electron in a V(η 5-C5H5)2L2-Type Complex”, J. Am. Chem. Soc., Vol. 97, (1975), pp. 6422–6233.

    Article  CAS  Google Scholar 

  22. P. Gowik and T. Klapötke: “Why Do Organometallic Hexafluoropnicogenate Complexes Show Biocidal Activity-a Study to the Structure Activity Correlation”, Monatshefte Für Chemie, Vol. 120, (1989), pp. 711–714.

    Article  CAS  Google Scholar 

  23. K. Mross, P. Robben-Bathe, L. Edler, J. Baumgart, W.E. Berdel, H. Fiebig and C. Unger: “Phase I clinical trial of a day-1,-3,-5 every 3 weeks schedule with titanocene dichloride (MKT 5) in patients with advanced cancer-A study of the phase I study group of the Association for Medical Oncology (AIO) of the German Cancer Society”, Onkologie, Vol. 23, (2000), pp. 576–579.

    Article  Google Scholar 

  24. G. Wilkinson and J.M. Birmingham: “Bis-Cyclopentadienyl Compounds of Ti, Zr, V, Nb and Ta”, J. Am. Chem. Soc., Vol. 76, (1954), p. 4281.

    Article  CAS  Google Scholar 

  25. J. Krzystek, A. Sienkiewicz, L. Pardi and L.C. Brunel: “DPPH as a Standard for High-Field EPR”, J. Magn. Reson., Vol. 125, (1997), pp. 207–211.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Vinklárek, J., Honzíček, J. & Holubová, J. Inclusion compounds of cystostatic active (C5H5)2VCl2 and (CH3C5H4)2VCl2 with α-, β- and γ-cyclodextrines: Synthesis, EPR study and microbiological behavior toward Escherichia coli. cent.eur.j.chem. 3, 72–81 (2005). https://doi.org/10.2478/BF02476239

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.2478/BF02476239

Keywords

Navigation